Past Issues – Page 6 – The Cancer Letter

Past issues are only available to subscribers. If you are not a member, click here to join.

Issue 13 - Mar. 29, 2019

TCL45-13 (257 downloads)

Guest Editorial
NCCN validates path toward de-escalated doses and reduced costs of cancer Drugs
The ever-rising cost of oncology drugs is doing damage to cancer care on many levels.
Annual total cost increases are projected to be as much as 20 percent annually. The intense financial pressure these costs place on our patients, even well-insured patients, is well documented.
Cancer is a model for drug development, FDA-bound Sharpless says to NCI advisors
Decades of basic research in oncology are paying off, resulting in an unprecedented number of drug approvals, said Ned Sharpless, the NCI director who is set to become FDA acting commissioner.
Guest Editorial
Congress must commit to sustained increases for NCI
Cancer is a relentless disease that impacts millions of Americans.
Just this year more than 1.7 million people in the U.S. are expected to be diagnosed with cancer, and over 600,000 Americans will die from the disease.
Letter to the Editor
Gundry: saguaro cacti do not grow in Texas
I enjoy your publication and read it cover to cover most weeks. But I must point out a glaring error in your recent edition of March 22. The illustrations accompanying the article about the Texas cancer researchers show saguaro cacti. Saguaro cacti only grow in the Sonoran desert of southern Arizona and western Sonora, Mexico, with a few stray saguaros in California. The saguaro cactus does not grow in Texas. It is a common misconception that the saguaro grows throughout the west. The cactus is so unique to Arizona that the saguaro cactus blossom has been named the state flower of Arizona. I thought you should be made aware of this inaccuracy.
AACR News
- Antoni Ribas named AACR president-elect for 2019-2020 term
- Daniel Von Hoff, Louis Weiner, Nancy Goodman to receive AACR Distinguished Public Service Awards
- AACR announces 2019 Class of Fellows of the AACR Academy
In Brief
- Sara Hook named associate director for NCI at Frederick
- GW Cancer Center receives $4M award for technical assistance to CDC National Comprehensive Cancer Control Program grantees
- Groups urge Congress to close Medicare loophole for colorectal cancer screenings
- Ali McBride to serve as ACCC president 2019-2020
Funding Opportunities
DoD Kidney Cancer Research Program- Funding Opportunities for FY19
The FY19 Defense Appropriation provides $20 million to the Department of Defense Kidney Cancer Research Program to support research of exceptional scientific merit in the area of kidney cancer.
Conversation with The Cancer Letter
Lee Schwartzberg tells us how three practices banded together to adapt to today’s cancer care and data revolution
Community oncology needs to adapt to the era of precision oncology and Big Data, said Lee Schwartzberg, executive director of Memphis-based West Cancer Center, who was recently named medical director of OneOncology, a partnership between three oncology practices located in Tennessee and New York.
Clinical Roundup
- Fulvestrant plus Anastrozole extends lives of women with advanced HR+ breast cancer
- Study finds heating up tumors could make CAR-T therapy more effective
- Study shows patients with or without cancer use different forms of marijuana
- Study may explain why immunotherapy not effective for some patients with metastatic melanoma and kidney cancer
Drugs & Targets
- FDA advances policy changes to modernize mammography services
- FDA issues alert on the investigational use of Venclexta in multiple myeloma
- Janssen submits application for Darzalex combination in multiple myeloma
- Breath Diagnostics, Mayo collaborate to develop diagnostic using patients’ exhaled breath to detect lung cancer
- Oncoceutics and NCI partner to develop ONC206
- Elicio Therapeutics launches vaccine & immunotherapy platform

Issue 12 - Mar. 22, 2019

TCL45-12 (239 downloads)

Texas cancer researchers vying to renew CPRIT beyond its 2023 sunset date
The institute is spending more than NCI in the state
The Cancer Prevention and Research Institute of Texas—the second largest publicly-funded granting organization for cancer after NIH—may receive $3 billion more to stay open past its current sunset date in 2023.
Conversation with The Cancer Letter
James Willson: CPRIT is money well spent
Advocates of renewing the Cancer Prevention and Research Institute of Texas argue that the agency is a good investment for the state.
In Brief
- Françoise Mornex becomes first female recipient of Heine H. Hansen Award
- Gift to UPMC Children’s Hospital of Pittsburgh establishes treatment suite for rare early childhood cancer
Funding Opportunities
DoD Prostate Cancer Research Program announces funding opportunities
The FY19 Defense Appropriation provides $100 million to the Department of Defense Prostate Cancer Research Program to support innovative, high-impact prostate cancer research.
Trials & Tribulations
SWOG’s 1501 study takes aim at the silo wall between cardiology and oncology
Many have written and spoken about the goal of eliminating the effect of developing and delivering medical care in “silos.”
Clinical Roundup
- Breast ultrasound and cancer detection rates increased under new laws
- Duke study says genomic testing associated with lower health care costs in high-risk breast cancer patients
- Braftovi with Mektovi + Erbitux or panitumumab recommended in advanced BRAF-mutant colorectal
- Data from GARNET study indicates robust activity of dostarlimab in endometrial cancer
Drugs & Targets
- Tecentriq + chemo gets FDA approval in extensive-stage SCLC
- Strata Oncology launches expanded StrataNGS
- Oncoceutics and NCI collaborate to develop ONC206
- FDA issues warning letters to breast implant manufacturers to deliver on post-approval requirements

Issue 11 - Mar. 15, 2019

TCL45-11 (298 downloads)

News Analysis
The Gottlieb-Sharpless-Lowy rearrangement
No prizes should be handed out to anyone who predicted that:
1. Scott Gottlieb would leave his job as FDA commissioner,
2. Gottlieb would suggest NCI Director Ned Sharpless as his replacement, and
3. NCI Deputy Director Doug Lowy would step in as NCI acting director.
Trump proposal for FY2020 to slash NIH by 12 percent, NCI by 15 percent
President Donald Trump has proposed to cut $4.7 billion from the NIH budget, with almost $900 million coming out of NCI during the fiscal year 2020.
AACR News
DuBois to receive Magaret Foti award; Freireich–Lifetime Achievement award; Hudson and Robison–Team Science award
The American Association for Cancer Researc will honor the following cancer researchers, clinicians, and physician-scientists at the AACR Annual Meeting 2019, to be held March 29-April 3 in Atlanta.
ASCO News
Hortobagyi to deliver Karnofsky lecture; Brugge–Science of Oncology lecture; Wolmark–Gianni Bonadonna lecture
The American Society of Clinical Oncology and ASCO’s Conquer Cancer Foundation announced the winners of Special Awards, the society’s highest honors, and Conquer Cancer’s Women Who Conquer Cancer Mentorship Awards.
In Brief
- Fred Hirsch to join Mount Sinai Tisch Cancer Institute
- Reps. Higgins, Guthrie, Matsui and Bilirakis announce the Cancer Drug Parity Act
- Ong named a finalist in the 25th Annual NIHCM Research and Journalism Awards
Conversation with The Cancer Letter
TMIST PI Pisano: “Are we further reducing breast cancer mortality the more intensively we screen?”
The Tomosynthesis Mammographic Imaging Screening Trial, a massive randomized trial of early detection, is asking an important question:
Is digital breast tomosynthesis better than digital mammography in reducing development of advanced breast cancer?
Clinical Roundup
- UAMS study shows potential to alter neck dissection surgery in head and neck cancer
Drugs & Targets
- European Commission approves Keytruda + chemotherapy for NSCLC
- Tecentriq + Abraxane regimen gets accelerated approval for breast cancer
- Trazimera, Herceptin biosimilar, gets FDA approval
- myPath melanoma test receives Medicare coverage

Page 6 of 109« First «...2 3 4 567 8 9 10 11...20 30 40 50 60 70 80 90 100...»Last »